----------------------------------------------
------------------------------------------------------------------
As you can probably imagine, efforts within the medical field are going to be had in a number of different fashions. Some of them may include the usage of mice, which isn't hard to see why. They react to certain therapies in different ways, which means that the results could most likely play into human usage as well. Brain tumor research is no exception and it seems like there has been some attention brought to human cells in mice recently, which has gone on to earn my attention as well.
According to Science Daily, John Hopkins researchers have been working hard to see how mice react to a certain FDA-approved drug. However, in order to make this viable in the field of brain tumor research, the mice were treated as they had human tumor cells in their bodies. What's even more interesting than this is that the drug showed a halting of such tumors and there was no trace to be found as well. To say that this story deserves the attention of organizations like Voices against Brain Cancer would be an understatement.
The story went into detail about a mutation that was spotted within the IDH1 gene in 2008. For those who do not know what this gene entails, it is a rather common element that has been seen in about 70 to 80 percent of lower-grade tumors. With this mutation, the brain has difficulty bringing glucose into effect, transitioning it to an energy form so that the body can utilize it. It's apparent that there are challenges when you're talking about this field in particular and it's not hard to see why.
Everyone is going to be different in terms of the condition they have, meaning that different methods are going to be set in place. Tumors may be prevalent but the specific types couldn't be more different from one another in terms of how they are structured. Many different components can be brought into account in order to help research along. Knowing that there is a chance for these tumor cells to slow own before ultimately fading away brings a sense of hope to this matter in the medical field.
In my eyes, brain tumor research is one of those fields that have so much attention brought to it for the right reasons. Finding solid cures has proven to be a challenge but therapies seem to be built more and more over the course of time. It seems like some of them have proven to be successful, which has the case with this particular trial. Whether or not this will translate into human use remains to be seen but I am confident that results will rise to the surface.
According to Science Daily, John Hopkins researchers have been working hard to see how mice react to a certain FDA-approved drug. However, in order to make this viable in the field of brain tumor research, the mice were treated as they had human tumor cells in their bodies. What's even more interesting than this is that the drug showed a halting of such tumors and there was no trace to be found as well. To say that this story deserves the attention of organizations like Voices against Brain Cancer would be an understatement.
The story went into detail about a mutation that was spotted within the IDH1 gene in 2008. For those who do not know what this gene entails, it is a rather common element that has been seen in about 70 to 80 percent of lower-grade tumors. With this mutation, the brain has difficulty bringing glucose into effect, transitioning it to an energy form so that the body can utilize it. It's apparent that there are challenges when you're talking about this field in particular and it's not hard to see why.
Everyone is going to be different in terms of the condition they have, meaning that different methods are going to be set in place. Tumors may be prevalent but the specific types couldn't be more different from one another in terms of how they are structured. Many different components can be brought into account in order to help research along. Knowing that there is a chance for these tumor cells to slow own before ultimately fading away brings a sense of hope to this matter in the medical field.
In my eyes, brain tumor research is one of those fields that have so much attention brought to it for the right reasons. Finding solid cures has proven to be a challenge but therapies seem to be built more and more over the course of time. It seems like some of them have proven to be successful, which has the case with this particular trial. Whether or not this will translate into human use remains to be seen but I am confident that results will rise to the surface.
About the Author:
Visit Voices Against Brain Cancer if you're looking for more information about glioblastoma research.. Unique version for reprint here: Cells In Mice Seen By Brain Tumor Research.
0 comments:
Post a Comment